Skip to main content
Premium Trial:

Request an Annual Quote

National Jewish Health Partners with LabCorp on Molecular Dx

NEW YORK (GenomeWeb News) – Denver research hospital National Jewish Health will collaborate with Laboratory Corporation of America to develop and commercialize molecular diagnostic tests for respiratory, immune, and related diseases, the hospital said today.
The hospital and LabCorp have “established a framework for discovery, development, and commercialization of diagnostic tests,” National Jewish Health said.
Gary Smith, director of National Jewish Health’s Advanced Diagnostics Laboratory, said in a statement that the collaboration “will allow us to provide specialized companion diagnostic tools to a much broader audience."
Financial terms of the agreement were not disclosed.